SUPERNUS PHARMACEUTICALS INC (SUPN)

US8684591089 - Common Stock

35.82  -0.3 (-0.83%)

After market: 35.82 0 (0%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to SUPN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 40.04. This target is 11.77% above the current price.
SUPN was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SUPN.
In the previous month the buy percentage consensus was at a similar level.
SUPN was analyzed by 10 analysts. More opinions would make the average more meaningful.

Related screens

Price Target & Forecast

Price Low Median Mean High 35.8236.3639.7840.0445.15 - 1.51% 11.06% 11.77% 26.05%

Related screens

Up and Down Grades
Date Firm Action Rating
2024-09-11 Piper Sandler Downgrade Overweight -> Neutral
2024-02-28 Piper Sandler Maintains Overweight -> Overweight
2023-11-09 Piper Sandler Maintains Overweight -> Overweight
2023-10-25 Piper Sandler Maintains Overweight -> Overweight
2023-05-10 Piper Sandler Maintains Overweight -> Overweight
2023-01-23 Piper Sandler Maintains Overweight
2022-08-31 Piper Sandler Maintains Overweight
2021-04-13 Jefferies Upgrade Hold -> Buy